Home / Inspections / 811362

FDA Inspection 811362 — Eurofins Biopharma Product Testing, Denmark A/S

Eurofins Biopharma Product Testing, Denmark A/S — FEI 3006272083

The FDA completed an inspection of Eurofins Biopharma Product Testing, Denmark A/S on December 14, 2012 in Glostrup. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 14, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Glostrup (Denmark)

Facility

Other inspections at this facility

  • 1222906 (NAI Wed May 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 976102 (VAI Wed Jun 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 780431 (NAI Fri Mar 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 578807 (VAI Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources